Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lisata Therapeutics, Inc. - Common Stock (NQ:LSTA)

1.090 UNCHANGED
Delayed Quote Updated: 4:00 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.090
Bid (Size) 0.9900 (300)
Ask (Size) 1.220 (400)
Prev. Close 1.090
Today's Range 1.090 - 1.090
52wk Range 0.9604 - 5.070
Shares Outstanding 60,533,064
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
Veteran biopharma CFO brings more than 15 years of public-company financial leadership across development, approval and commercial launch; joins Audit Committee 
From Lisata Therapeutics, Inc.
Via GlobeNewswire
News headline image
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
From Lisata Therapeutics, Inc.
Via GlobeNewswire

Performance

52-Week Range 78.5% below 52-week high
1.090
0.9652W Low 5.0752W High
1 Week 5.1% below 1-week high
0.991W Low 1.151W High

Lisata Therapeutics, Inc. - Common Stock (LSTA) traded between $0.96 and $5.07 over the past 52 weeks and last traded at $1.09, 78.5% below its 52-week high. Over the past week it ranged between $0.99 and $1.15.

Past 12 Months
+2.8%
-13.5%
-4.4%
-66.7%
-44.4%
-59.2%
1W +$0.03
1M -$0.17
3M -$0.05
6M -$2.18
YTD -$0.87
1Y -$1.58

LSTA was -59.2% over the past year, -66.7% over six months, -44.4% year to date, +2.8% in the last week.

12 Months vs Market
LSTA
-59.2%
DIA
+9.2%
SPY
+10.4%
QQQ
+8.4%
IWM
+14.0%

Over the past 12 months LSTA returned -59.2% versus DIA (Dow) +9.2%, SPY (S&P 500) +10.4%, QQQ (Nasdaq 100) +8.4% and IWM (Russell 2000) +14.0%.

Volume & Liquidity
1W
58.1K
1M
109.5K
3M
282.8K
6M
204.4K
YTD
183.1K
1Y
165.8K

LSTA's 3-month average daily volume is 282.8K.

More News

Read More
News headline image
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
From Lisata Therapeutics, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether BWIN, LSTA, ACVA are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
From Lisata Therapeutics, Inc.
Via GlobeNewswire
News headline image
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
From Lisata Therapeutics, Inc.
Via GlobeNewswire
News headline image
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
From Lisata Therapeutics, Inc.
Via GlobeNewswire
These stocks are moving in today's after hours session ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
The market is filled with gapping stocks in Tuesday's session. ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
From Lisata Therapeutics, Inc.
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: KalVista Pharmaceuticals, Inc. (Nasdaq – KALV), Thermon Group Holdings, Inc. (NYSE – THR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq –
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether NSA, LSTA, TALK are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether SILA, LSTA, ESPR are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Esperion Therapeutics, Inc. (Nasdaq – ESPR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA), SkyWater Technology, Inc. (Nasdaq -
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether SILA and LSTA are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether TALK, UBFO, LSTA are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
From Lisata Therapeutics, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC Reminds Shareholders of SKYT, NATH, SNCY, LSTA of the Firm’s Investigations
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SkyWater Technology, Inc. (Nasdaq - SKYT), Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages NATH, PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages SKYT, NATH, LSTA Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill

Frequently Asked Questions

Is Lisata Therapeutics, Inc. - Common Stock publicly traded?
Yes, Lisata Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Lisata Therapeutics, Inc. - Common Stock trade on?
Lisata Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lisata Therapeutics, Inc. - Common Stock?
The ticker symbol for Lisata Therapeutics, Inc. - Common Stock is LSTA on the Nasdaq Stock Market
What is the current price of Lisata Therapeutics, Inc. - Common Stock?
The current price of Lisata Therapeutics, Inc. - Common Stock is 1.090
When was Lisata Therapeutics, Inc. - Common Stock last traded?
The last trade of Lisata Therapeutics, Inc. - Common Stock was at 11/03/26 04:00 PM ET
What is the market capitalization of Lisata Therapeutics, Inc. - Common Stock?
The market capitalization of Lisata Therapeutics, Inc. - Common Stock is 65.98M
How many shares of Lisata Therapeutics, Inc. - Common Stock are outstanding?
Lisata Therapeutics, Inc. - Common Stock has 66M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.